Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

NCT06613698 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.

NCT04066179 ·Status: UNKNOWN ·Phase: NA

Effect of Indian Hepatoprotective Diet in Reversibility of NAFLD

NCT05696808 ·Status: UNKNOWN ·Phase: NA

Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

NCT04140123 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH

NCT05462353 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

NCT04565717 ·Status: TERMINATED ·Phase: PHASE1

RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver Disease

NCT03365531 ·Status: TERMINATED ·Phase: NA

Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis

NCT01820208 ·Status: COMPLETED ·Phase: NA

A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT05692492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

NCT03656744 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT03551522 ·Status: TERMINATED ·Phase: PHASE2

A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases

NCT02077374 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

NCT03053063 ·Status: TERMINATED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

NCT00740610 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

NCT03053050 ·Status: TERMINATED ·Phase: PHASE3

Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)

NCT00681733 ·Status: UNKNOWN ·Phase: NA

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

NCT05028829 ·Status: RECRUITING ·Phase: PHASE2

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

NCT06891365 ·Status: RECRUITING ·Phase: PHASE1

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

NCT02868164 ·Status: WITHDRAWN ·Phase: NA

Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children

NCT05073588 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

NCT06750276 ·Status: COMPLETED ·Phase: PHASE2

Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

NCT05560607 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

NCT05917938 ·Status: COMPLETED ·Phase: PHASE1

Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.

NCT02721264 ·Status: UNKNOWN ·Phase: NA

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

NCT03912532 ·Status: COMPLETED ·Phase: PHASE2